← brief for 2026-11-04 · Slowing decline
Liver-targeted drug delivery systems of traditional Chinese medicine: a novel strategy for the treatment of fatty liver disease
Key takeaways
This review discusses new ways to deliver traditional Chinese medicine drugs to the liver. It mentions the link between fatty liver and kidney disease. It is a review of strategies, not a report of new clinical trial results.
Who did this work
Letao Zhao (Heilongjiang University of Chinese Medicine) · Yongji Li (Heilongjiang University of Chinese Medicine) · Jinjin Dou (Heilongjiang University of Chinese Medicine) · Ran Chen (Heilongjiang University of Chinese Medicine) · Yuan Liu (Heilongjiang University of Chinese Medicine) · 丹毅 冯 (Heilongjiang University of Chinese Medicine) · Hailing Zhang (Heilongjiang University of Chinese Medicine) · 张喜武 (Heilongjiang University of Chinese Medicine)
Source
Article · OpenAlex, CKD works · 2026-11-03
https://doi.org/10.3389/fphar.2026.1996171